DrugCLIP screens about 10,000 human proteins against 500 million compounds
The January 2026 Science abstract reports DrugCLIP screening roughly 10,000 human proteins against 500 million compounds. Experimental hits included 15% for the norepinephrine transporter, with structures of two inhibitor complexes, and 17.5% for TRIP12 using AlphaFold2 structures. Most database results remain computational. The work also has a bioRxiv preprint first indexed in September 2024.
Technology: DrugCLIP (deep contrastive learning)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Biochemical hit testing and structures of two NET inhibitor complexes.
- Still unknown: Not assessed: full assay denominators, uncertainty and genome-wide experimental coverage.
- AI role: Contrastive learning ranked protein-compound pairs.
Evidence sources: https://pubmed.ncbi.nlm.nih.gov/41505557/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.